Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without CirrhosisKris V. Kowdley, Michael Fried, Eric Lawitz et al.|New England Journal of Medicine|2014Cited by 1.1k
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary CholangitisFrederik Nevens, Д. А. Шапиро, Pietro Andreoné et al.|New England Journal of Medicine|2016Cited by 1.1k
All‐oral 12‐week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY‐3 phase III studyDavid R. Nelson, James N. Cooper, Jacob Lalezari et al.|Hepatology|2015Cited by 689